iNDX.Ai is a silicon valley based Bio-IT company established on 18th March 2011 and has developed iCore, an innovative informatics platform which delivers novel insights and accelerates the drug development process for precision medicine.
We are a highly motivated team of entrepreneurs, doctors, engineers, and data scientists with a mission to develop innovative software products that can help our collaborators find a cure for cancer and make a global societal impact. Our tight-knight team comprises of accomplished founders and experienced management professionals with a proven track record that boasts successful establishment of five companies, efforts that have generated $50M in investment, and portfolios that have amassed an exit value surpassing $500M
We provide the most advanced, accessible, and comprehensive suite of software solutions in the field of translational research. Our offerings enable users to aggregate, analyze, visualize, interrogate biomedical data and gather strategic and predictive insights in a secure cloud-based environment.
Problems We Are Solving
The genomics revolution has created a data tsunami. We have developed a novel approach for managing Immuno-Oncology clinical trials and translational research. Our software suite is solving the following problems.
- Difficulties in correlating clinical data and exploratory data
- Problems related to understanding the MOA for new clinical trial candidates
- Issues related to proper monitoring of the subject’s health during a clinical trial
- Roadblocks in the analysis of diverse multi-omics and clinical datasets that prevent investigators in gathering predictive insights
“Our vision is to build an innovative platform to help find Right Medicine for the Right Patient at the Right Time, across the town or around the world. We are looking for a few good men and women across different disciplines who have passion for this mission and take great pride in building game-changing products and solutions for cancer patients around the world and who believe in our principles”
“Our mission is to be the Tech-Catalyst and help our collaborators/customers to find a cure for cancer.
It is our firm belief that the intersection of Innovations in Technology, Science and Business is the only way
to fight this deadly disease.”
Highly skilled employees in multidisciplinary teams
Offices in USA and India, Partnered with Avantor in Europe
Global Standards in Data Protection
Biospecimen workflow for efficient trial operations
Actionable biological insights
Overcome insights missed by traditional bioinformatics tools.
Leveraging AI, ML and NLP
View our 2019 Company brochure for an easy to read guide on our offered product.
Accelarating biomarker discovery in I/O using AI
Collaborative case study for Academic centres
Founded in 2005 and backed by Artiman Ventures and Sequoia Capital, Cellworks has built the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers, semiconductor engineers, and internet software architects working towards a common goal of fighting disease to improve the lives of patients. Cellworks’ areas of therapeutic focus are oncology, immunology, dermatology and infectious diseases. Cellworks’ mission is to serve patients through advances in precision medicine that significantly improve treatment success.
Strand Life Sciences: Strand Life Sciences is a clinical research and diagnostics company that combines a long track record in bioinformatics with cutting-edge laboratory assays and a vast hospital partner network to drive newer generations of patient care. Strand’s customers include global instrument, diagnostic and pharmaceutical companies. Strand is also a pioneer of genomic testing in India. Strand’s diagnostics menu makes it India’s leading integrated specialized diagnostics company, covering oncology, genetics, fertility, women’s health, infectious diseases and general wellness.
The American Association for Cancer Research (AACR) is the world’s oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 34,000 members in over 90 countries.
The American Society of Clinical Oncology (ASCO) is a professional organization
representing physicians of all oncology sub-specialties who care for people with cancer.
Founded in 1964 by Drs. Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, ASCO has nearly 45,000 members worldwide.
The Society for Immunotherapy of Cancer (SITC), previously known as The International Society for Biological Therapy of Cancer (iSBTc) is a professional society of influential scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.